Major Depressive Disorder Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Adjunctive NBI 1065845 in Adult Subjects With Major Depressive Disorder (MDD) (SAVITRI STUDY)
The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo used in addition to oral antidepressants in adults with MDD on improving symptoms of depression.
n/a
| NCT number | NCT05203341 |
| Study type | Interventional |
| Source | Neurocrine Biosciences |
| Contact | Neurocrine Medical Information Call Center |
| Phone | 877-641-3461 |
| [email protected] | |
| Status | Recruiting |
| Phase | Phase 2 |
| Start date | February 21, 2022 |
| Completion date | October 2023 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
| Recruiting |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
| Suspended |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
Early Phase 1 | |
| Recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
| Active, not recruiting |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
| Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
| Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
| Active, not recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
| Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
| Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
| Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
| Recruiting |
NCT04422652 -
Combination of Novel Therapies for CKD Comorbid Depression
|
Phase 2 | |
| Completed |
NCT04799405 -
Home-based tDCS in Major Depressive Disorder
|
N/A | |
| Recruiting |
NCT03708159 -
Maintenance of Response After rTMS for Depression Using tDCS
|
N/A | |
| Recruiting |
NCT03363919 -
Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression
|
N/A | |
| Recruiting |
NCT04727229 -
Stellate Ganglion Block for Major Depressive Disorder.
|
Phase 4 | |
| Enrolling by invitation |
NCT04634669 -
Open-Label Safety Study of AXS-05 in Subjects With TRD
|
Phase 2 | |
| Recruiting |
NCT03307070 -
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
|
N/A | |
| Completed |
NCT03113890 -
McLean and Genomind Prospective Study
|
N/A | |
| Not yet recruiting |
NCT05227612 -
Psilocybin-assisted CBT for Depression
|
Early Phase 1 |